Challenges and Controversies in Breast Surgery
- PMID: 31558891
- PMCID: PMC6751473
- DOI: 10.1159/000502134
Challenges and Controversies in Breast Surgery
Conflict of interest statement
Prof. Gnant has received institutional research support from AstraZeneca, Roche, Novartis, and Pfizer, and has received lecture fees, honoraria for participation on advisory boards, and travel support from Amgen, AstraZeneca, Celgene, EliLilly, Invectys, Pfizer, Nanostring, Novartis, Roche, and Medison. He has served as a consultant for AstraZeneca and EliLilly, and an immediate family member is employed by Sandoz.
References
-
- Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, et al. Cancer Staging Manual. 8th ed. New York (NY): Springer; 2017. American Joint Committee on Cancer (AICC)
-
- Yerushalmi R, Kennecke H, Woods R, Olivotto IA, Speers C, Gelmon KA. Does multicentric/multifocal breast cancer differ from unifocal breast cancer? An analysis of survival and contralateral breast cancer incidence. Breast Cancer Res Treat. 2009 Sep;117((2)):365–70. - PubMed
Publication types
LinkOut - more resources
Full Text Sources